You are here

Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children.

Pubmed ID: 
24943261
Year: 
2014
Month: 
SEP
Volume: 
12
Issue: 
9
Citation: 
Greene LA, Law C, Jung M, Walton S, Ignjatovic V, Monagle P, Raffini LJ. Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. Journal of thrombosis and haemostasis : JTH 12 (9) : 1554 - 7(2014) PubMed